Navigation Links
Pharmion and MethylGene Initiate Phase One Combination Clinical Trial with MGCD0103 and Taxotere(R) in Patients with Solid Tumors
Date:10/10/2007

BOULDER, Colo. and MONTREAL, Oct. 10 /PRNewswire-FirstCall/ -- Pharmion Corporation (Nasdaq: PHRM) and MethylGene Inc. (TSX: MYG) today announced the initiation of a Phase One clinical trial evaluating MGCD0103, the Companies' isotype-selective histone deacetylase inhibitor (HDACi) product candidate, in combination with Taxotere(R) (docetaxel; Sanofi Aventis) in patients with solid tumors. Taxotere is an approved chemotherapy agent marketed for use in breast, lung, prostate, gastric and head and neck cancer.

In the first portion of the trial, MGCD0103 will be given orally, three times per week for three weeks in combination with Taxotere, which will be administered on Day 1 of each three-week cycle to patients with cancer where treatment with Taxotere is approved or considered standard of care, or patients who have no available standard of care therapeutic options. Key objectives for this portion of the study will be threefold: to evaluate the safety of administering these two agents together; determine the maximum tolerated dose of MGCD0103 when combined with the two fixed doses of Taxotere; and to define optimal dosing for the second portion of the trial. In the second portion of the trial, objectives include further assessment of the safety of the drug combination, quantification of tumor responses and measurement of the pharmacodynamic and pharmacokinetic characteristics. The trial may enroll up to 50 patients at cancer centers in North America. The trial is expected to take 12 to 18 months to complete.

"This is an important step forward in the clinical development of MGCD0103," said Andrew Allen, executive vice president and chief medical officer of Pharmion Corporation. "Cytotoxic chemotherapies such
'/>"/>

SOURCE Pharmion Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Pharmions Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
2. Pharmion to Present Clinical Data on Commercial and Pipeline Products at 2007 American Society of Clinical Oncology (ASCO) Meeting
3. Malvern initiates European user group meetings for chemical imaging
4. Protalix BioTherapeutics, Inc. Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD
5. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
6. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2008)...creased information density, automation and intell...cy in ultrasound to an all new level , , CH...emens Healthcare ( www.siemens.com/healthcare )... Volume Scanner (ABVS)(1), the world,s first mult...at the 94th Scientific Assembly and Annual Meeting...
(Date:11/25/2008)...mptom awareness can improve recovery , , Au...y are available on the Mayo Clinic News Blog. Plea... , , ROCHESTER, Minn., Nov. 25 /PRNewswire...ty of stroke patients don,t think they,re having a...ent until their condition worsens. The findings ap...
(Date:11/25/2008)...sults reveal most respondents against expanding st... , LITTLE FALLS, N.J., Nov. 25 /PRNewswire/ ...in may lower the cardiovascular risk of healthy pa...sal statin use in older adults, according to a nat...1,212 participants took part in the online poll co...
(Date:11/25/2008)...UTH SAN FRANCISCO, Calif., Nov. 25 /PRNewswire-Fir... PARD ), a biopharmaceutical company focused on,...at it will be exploring,strategic alternatives fo...low,the Company to focus its resources on the cli... candidate, and to support the initial commerciali...
Breaking Medicine Technology:Siemens Introduces New Standard of Care for Breast Ultrasound 2Siemens Introduces New Standard of Care for Breast Ultrasound 3Siemens Introduces New Standard of Care for Breast Ultrasound 4Siemens Introduces New Standard of Care for Breast Ultrasound 5Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 3Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 2Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 3Study questions impact of hemoglobin variations on mortality in dialysis patients 7637 1Study questions impact of hemoglobin variations on mortality in dialysis patients 7637 2Survey Shows Broad Support Among Americans for Pharmacy Technician Certification 7632 1Survey Shows Broad Support Among Americans for Pharmacy Technician Certification 7632 2Managing the Service to Sales Cultural Transformation Complimentary Excerpt Available from Best Practices 7627 1Managing the Service to Sales Cultural Transformation Complimentary Excerpt Available from Best Practices 7627 2Escape the Cold and Flu Season With a Free Vacation to the Sunshine State 7622 1Escape the Cold and Flu Season With a Free Vacation to the Sunshine State 7622 2
...ically effective in a,mouse model of Chronic Lymph...taris Pharma, the Danish,biopharmaceutical company...aging data at the American Association for Cancer,...at SPC2996, the,Company,s RNA Antagonist of Bcl-2,...of human Chronic Lymphocytic Leukaemia (CLL). , In...
...for Cancer Research Annual,Meeting, SAN DIEGO, Apr...rmaceuticals, Inc. , a biopharmaceutical research ... proprietary product,candidates for the treatment ... positive results from preclinical studies using a...Factor(R)) at the,American Association for Cancer ...
Other Medicine Technology:Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 2Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 3Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 4Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 5Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 6Adventrx Announces Positive Data From Multidrug Therapy With,CoFactor 2Adventrx Announces Positive Data From Multidrug Therapy With,CoFactor 3Adventrx Announces Positive Data From Multidrug Therapy With,CoFactor 4
(Date:12/1/2008)...the agency,s goals, commitment and resources , ...onding to criticism that it has done a poor job sa... and Drug Administration released a report Monday ...mong the most important changes in 2008 was the ag...th state and local health departments to protect t...
(Date:12/1/2008)...tional Cancer Institute,s cancer registry has foun...ce delayed or incomplete radiation treatment follo...ptimal care can lead to worse outcomes. , Dr. He... and colleagues found that among a nationally repr...gistry patients aged 65 and older, almost 1,300 wo...
(Date:12/1/2008)... Due to the urgent need to dissemi...S/HIV research and clinical care, publisher Mary... access to all archival online issues of the compa...honor of World AIDS Day. Free online access is ava...ebertpub.com/apc ) and AIDS Research and Human R...
(Date:12/1/2008)...wire-USNewswire/ -- Americans United for Life (A...egislative resolution opposing the federal "Freedo...ures to adopt the resolution immediately when they...aine Yoest, AUL President & CEO said, "The so-...ealth. It protects and promotes the abortion indu...
Breaking Medicine News(10 mins):Health News:FDA Touts Efforts to Enhance Food Safety 2Health News:FDA Touts Efforts to Enhance Food Safety 3Health News:FDA Touts Efforts to Enhance Food Safety 4Health News:Delays in radiation therapy lead to increased breast cancer recurrence 2Health News:Mary Ann Liebert, Inc. Provides Free Online Journal Access in Recognition of World AIDS Day 2Health News:Americans United for Life Urges State Legislatures to Oppose Federal Power Grab: Provides Model Resolution Denouncing Freedom of Choice Act (FOCA) 2
...al safety rating until their safety and effectiven...n, experts have said in the latest Medical Journal...ome other prescription medicines, which were withd..., has shown that reliance on pre-marketing trials ...
...he more he or she consumes sugary drinks, and extr...or every one-hour increase in TV viewing per day, ...es including juice (one extra serving per week) an..." said Sonia Miller, B.A., lead author of the stud...
...permanent vascular damage in their children — incr...ccording to a research. The Netherlands Atherosc...hat participants who were exposed to smoke when th...permanent cardiovascular damage that could be dete...
... image-guided treatment of kidney tumors – cryoabl...nique in viable candidates. The research was prese...32nd Annual Scientific Meeting. The comparative ...tion results in a slightly lower recurrence rate o...
Other Medicine News:Health News:Time to Overhaul Australia's Medicines Safety Surveillance System 2Health News:Excessive TV Viewing Linked to Poor Eating Habits in Children 2Health News:Excessive TV Viewing Linked to Poor Eating Habits in Children 3Health News:Pregnant Smokers Raise Their Child's Risk of Stroke, Heart Attack 2Health News:Pregnant Smokers Raise Their Child's Risk of Stroke, Heart Attack 3Health News:Freezing Kidney Tumors Effective and Less Expensive Than Laparoscopy 2
...IgM Capture ELISA is for the qualitative presumpti...antigens (WNRA) in serum as an aid in the clinical... in patients with clinical symptoms consistent wit...e confirmed by Plaque Reduction Neutralization Tes...
Used for dilation of urethral strictures and/or drainage and irrigation of the bladder. The flare at the proximal end of the catheter fits a standard irrigation syringe. The distal tip is threaded to
Used to dilate the male or female urethra to treat stricture disease. Supplied sterile in peel-open packages. Intended for one-time use.
The removable inflation adapter allows the ureteroscope to be removed after the catheter is in place. Supplied sterile in peel-open packages. Intended for one-time use.
Medicine Products: